| Primary |
| Anxiety |
17.0% |
| Depression |
17.0% |
| Somatoform Disorder |
11.3% |
| Panic Attack |
9.4% |
| Ill-defined Disorder |
5.7% |
| Crohn's Disease |
3.8% |
| Insomnia |
3.8% |
| Nervousness |
3.8% |
| Pain In Extremity |
3.8% |
| Schizophrenia, Paranoid Type |
3.8% |
| Stress |
3.8% |
| Aerophagia |
1.9% |
| Back Pain |
1.9% |
| Burnout Syndrome |
1.9% |
| Injury |
1.9% |
| Menopausal Symptoms |
1.9% |
| Neurosis |
1.9% |
| Pain |
1.9% |
| Panic Disorder |
1.9% |
| Post-traumatic Stress Disorder |
1.9% |
|
| Weight Decreased |
9.8% |
| Suicide Attempt |
7.3% |
| Toxicity To Various Agents |
7.3% |
| Weight Increased |
7.3% |
| Withdrawal Syndrome |
7.3% |
| Drug Toxicity |
4.9% |
| Dyskinesia |
4.9% |
| Extremity Contracture |
4.9% |
| Muscle Spasms |
4.9% |
| Overdose |
4.9% |
| Parkinsonism |
4.9% |
| Somnolence |
4.9% |
| Status Epilepticus |
4.9% |
| Suicidal Ideation |
4.9% |
| Tremor |
4.9% |
| Asthenia |
2.4% |
| Death |
2.4% |
| Drug Withdrawal Syndrome |
2.4% |
| Epilepsy |
2.4% |
| Hyperprolactinaemia |
2.4% |
|
| Secondary |
| Drug Use For Unknown Indication |
71.6% |
| Product Used For Unknown Indication |
7.8% |
| Anxiety |
4.1% |
| Panic Disorder |
2.4% |
| Attention Deficit/hyperactivity Disorder |
1.7% |
| Depression |
1.7% |
| Munchausen's Syndrome |
1.5% |
| Panic Attack |
1.2% |
| Anticoagulant Therapy |
1.0% |
| Hypersensitivity |
1.0% |
| Pain |
1.0% |
| Prophylaxis |
1.0% |
| Neurosis |
0.7% |
| Back Pain |
0.5% |
| Burnout Syndrome |
0.5% |
| Crohn's Disease |
0.5% |
| Drug Therapy |
0.5% |
| Ill-defined Disorder |
0.5% |
| Injury |
0.5% |
| Insomnia |
0.5% |
|
| Weight Increased |
34.4% |
| Tremor |
10.9% |
| Sexual Dysfunction |
7.8% |
| Dyskinesia |
6.3% |
| Unevaluable Event |
6.3% |
| Hyperprolactinaemia |
3.1% |
| Memory Impairment |
3.1% |
| Nausea |
3.1% |
| Suicide Attempt |
3.1% |
| Thyroid Cancer |
3.1% |
| Urinary Retention |
3.1% |
| Withdrawal Syndrome |
3.1% |
| Asthenia |
1.6% |
| Drug Withdrawal Syndrome |
1.6% |
| Liver Injury |
1.6% |
| Muscle Spasms |
1.6% |
| Obsessive-compulsive Disorder |
1.6% |
| Overdose |
1.6% |
| Parkinsonism |
1.6% |
| Status Epilepticus |
1.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.9% |
| Depression |
15.4% |
| Drug Use For Unknown Indication |
11.6% |
| Anxiety |
6.7% |
| Pain |
5.2% |
| Breast Cancer |
4.4% |
| Prophylaxis |
3.5% |
| Sleep Disorder |
3.2% |
| Graft Versus Host Disease |
2.9% |
| Hypertension |
2.9% |
| Schizophrenia |
2.6% |
| Bipolar Disorder |
2.3% |
| Colorectal Cancer Metastatic |
2.3% |
| Rheumatoid Arthritis |
2.3% |
| Insomnia |
2.0% |
| Bipolar I Disorder |
1.5% |
| Hepatitis |
1.5% |
| Post-traumatic Stress Disorder |
1.5% |
| Asthma |
1.2% |
| Attention Deficit/hyperactivity Disorder |
1.2% |
|
| Weight Decreased |
9.3% |
| Muscle Spasms |
7.4% |
| Pleurothotonus |
7.4% |
| Weight Increased |
7.4% |
| Drug Abuse |
5.6% |
| General Physical Health Deterioration |
5.6% |
| Overdose |
5.6% |
| Pyrexia |
5.6% |
| Vomiting |
5.6% |
| Breast Cancer |
3.7% |
| Death |
3.7% |
| Endometrial Disorder |
3.7% |
| Fibromyalgia |
3.7% |
| Gambling |
3.7% |
| Hypomania |
3.7% |
| Leukopenia |
3.7% |
| Loss Of Consciousness |
3.7% |
| Ovarian Cyst Ruptured |
3.7% |
| Pruritus |
3.7% |
| Restlessness |
3.7% |
|
| Interacting |
| Drug Use For Unknown Indication |
87.5% |
| Pain Management |
12.5% |
|
| Respiratory Depression |
100.0% |
|
